Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicity.
Sera from patients with systemic infections caused by the opportunistic fungus Trichosporon beigelii have been shown to cross-react with anticryptococcal antibodies. We quantitatively compared the amounts of antigen produced and examined the expression of O-acetyl epitopes from 35 strains of T. beigelii isolated from deep and superficial infections. By counterimmunoelectrophoresis, 10 of 10 isolates from deep infections were positive for polysaccharide, compared with 7 of 13 isolates from superficial infections (P = 0.02). All 23 strains tested were positive for polysaccharide when screened by immunodot. By enzyme immunoassay, the cross-reactive antigen produced by deep isolates (n = 9) had a mean titer of 1:5,500. In contrast, superficial isolates (n = 22) produced significantly less antigen than the deep isolates (P < 0.001), with a mean titer of 1:700. Isolates from environmental sources (n = 3) were similar to the superficial isolates, with a mean titer of 1:600. The mean concentrations +/- standard errors of cross-reactive polysaccharide released by deep isolates and superficial isolates were 3.09 +/- 0.44 and 1.74 +/- 0.30 micrograms/ml, respectively, when measured by rocket immunoelectrophoresis (P = 0.02). O-Acetyl epitopes were detected on polysaccharide from 8 of 9 strains of T. beigelii isolated from deep sources, while only 2 of 12 superficial isolates expressed detectable O-acetyl epitopes (P = 0.01). Thus, while all isolates of T. beigelii tested were capable of producing glucuronoxylomannan-like cross-reactive antigen, pathogenic isolates produced significantly more antigen than superficial or environmental isolates. Furthermore, significantly more pathogenic isolates than superficial or environmental isolates expressed antigen that was O acetylated.
Lyman
C A
CA
Pediatric Branch, National Cancer Institute, Bethesda, Maryland.
Devi
S J
SJ
Nathanson
J
J
Frasch
C E
CE
Pizzo
P A
PA
Walsh
T J
TJ
D000107:Acetylation; D000942:Antigens, Bacterial / Q000276:immunology* / Q000302:isolation & purification; D001769:Blood / Q000382:microbiology; D003429:Cross Reactions; D003454:Cryptococcus / Q000276:immunology; D000939:Epitopes; D006801:Humans; D007122:Immunoelectrophoresis; D007124:Immunoenzyme Techniques; D009181:Mycoses / Q000382:microbiology*; D011134:Polysaccharides / Q000276:immunology* / Q000302:isolation & purification; D011135:Polysaccharides, Bacterial / Q000276:immunology* / Q000302:isolation & purification; D012867:Skin / Q000382:microbiology; D013183:Sputum / Q000382:microbiology; D014250:Trichosporon / Q000276:immunology* / Q000472:pathogenicity
D000942:Antigens, Bacterial; D000939:Epitopes; D011134:Polysaccharides; D011135:Polysaccharides, Bacterial; C027478:glucuronoxylomannan